Huey-Juan Lin Selected Research

Huey-Juan Lin Research Topics

Disease

26	Stroke (Strokes) 01/2022 - 03/2004
23	Ischemic Stroke 06/2022 - 11/2009
7	Atrial Fibrillation 01/2022 - 09/2010
3	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2022 - 04/2019
3	Hemorrhage 02/2018 - 06/2013
3	Transient Ischemic Attack 01/2015 - 05/2010
2	Atherosclerosis 11/2017 - 01/2015
2	Hypertension (High Blood Pressure) 02/2010 - 11/2009
1	Hypercholesterolemia 01/2022
1	Insulin Resistance 01/2022
1	Dyslipidemias (Dyslipidemia) 02/2021
1	Psychotic Disorders (Schizoaffective Disorder) 01/2021
1	Dementia (Dementias) 11/2020
1	Hyperlipidemias (Hyperlipidemia) 06/2019
1	Hyperglycemia 01/2018
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2017
1	Diabetes Mellitus 11/2017
1	Neurologic Manifestations (Neurological Manifestations) 11/2017
1	Genetic Risk Score 03/2017
1	Peripheral Arterial Disease 01/2015
1	Cerebral Hemorrhage 03/2014
1	Cerebral Infarction 01/2014
1	Complex Regional Pain Syndromes 09/2012
1	Trigeminal Neuralgia (Tic Douloureux) 09/2012
1	Neuralgia (Stump Neuralgia) 09/2012
1	Pain (Aches) 09/2012
1	Cancer Pain 09/2012
1	Coronary Artery Disease (Coronary Atherosclerosis) 02/2011
1	Infections 02/2011
1	Acute Coronary Syndrome 05/2010
1	Central Nervous System Vascular Malformations (Dural Arteriovenous Fistula) 02/2010
1	Intracranial Sinus Thrombosis (Sinus Thrombosis) 02/2010
1	Hemorrhagic Stroke 09/2009
1	Eosinophilia 09/2008
1	Disseminated Intravascular Coagulation 03/2004
1	Neoplasms (Cancer) 03/2004

Drug/Important Bio-Agent (IBA)

9	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2022 - 09/2010
4	AnticoagulantsIBA 01/2021 - 03/2017
4	4- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA 06/2019 - 12/2013
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 06/2013
3	CholesterolIBA 06/2019 - 06/2013
3	LipidsIBA 06/2019 - 05/2010
2	Triglycerides (Triacylglycerol)IBA 01/2022 - 06/2013
2	oxidized low density lipoproteinIBA 06/2019 - 06/2013
2	HDL CholesterolIBA 06/2019 - 06/2013
2	Estradiol (Delestrogen)FDA LinkGeneric 03/2017 - 01/2012
2	Estrogens (Estrogen)FDA Link 03/2017 - 01/2012
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2021
1	Antipsychotic Agents (Antipsychotics)IBA 01/2021
1	Dichlorodiphenyldichloroethane (DDD)IBA 01/2021
1	Quetiapine Fumarate (Seroquel)FDA Link 01/2021
1	Haloperidol (Haldol)FDA LinkGeneric 01/2021
1	1- (diethylaminopropyl)- 4- phenylpiperazineIBA 01/2021
1	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2021
1	Histamine (Histamine Dihydrochloride)FDA Link 11/2020
1	Proton Pump InhibitorsIBA 11/2020
1	AcidsIBA 11/2020
1	CreatinineIBA 06/2018
1	Dabigatran FDA Link 02/2018
1	idarucizumabIBA 02/2018
1	Blood Glucose (Blood Sugar)IBA 01/2018
1	Mitochondrial DNA (mtDNA)IBA 11/2017
1	Glutathione Disulfide (GSSG)FDA LinkGeneric 11/2017
1	8-Hydroxy-2'-DeoxyguanosineIBA 11/2017
1	PotassiumIBA 11/2017
1	SaltsIBA 11/2017
1	MagnesiumIBA 11/2017
1	Neuroprotective AgentsIBA 03/2017
1	A-factor (Streptomyces)IBA 01/2017
1	Cilostazol (Pletal)FDA LinkGeneric 01/2015
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2015
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2015
1	SPADIBA 01/2015
1	danaparoid (Orgaran)FDA Link 07/2014
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2014
1	LDL CholesterolIBA 06/2013
1	Estrogen ReceptorsIBA 01/2012
1	TransferasesIBA 01/2012
1	SulfotransferasesIBA 01/2012
1	Hormones (Hormone)IBA 01/2012
1	catechol (pyrocatechol)IBA 01/2012
1	Indicators and Reagents (Reagents)IBA 09/2010
1	PPAR gammaIBA 11/2009
1	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2008
1	Dacarbazine (DIC)FDA LinkGeneric 03/2004
1	Fibrinogen (Factor I)FDA Link 03/2004
1	Hemostatics (Antihemorrhagics)IBA 03/2004
1	formycin diphosphate (FDP)IBA 03/2004

Therapy/Procedure

8	Therapeutics 06/2022 - 09/2008
3	Length of Stay 06/2022 - 09/2009
2	Patient Readmission 02/2011 - 09/2009
1	Resuscitation Orders (Do Not Resuscitate Orders) 06/2022
1	Contraindications 03/2017
1	Secondary Prevention 01/2015
1	Thrombolytic Therapy 01/2014
1	Urinary Catheters 06/2013
1	Pain Management 09/2012
1	Off-Label Use 09/2012
1	Polypharmacy 09/2012
1	Stents 02/2010